Propanc Biopharma Inc. (PPCB)

NasdaqCM: PPCB · 即時價格 · USD

1.35

-0.88 (-39.46%)

收盤價： Aug 28, 2026, 8:00 PM

1.36

+0.74%

盤後: 7:59 PM

股價、關鍵數字和最新消息，都在這一頁。

-39.46% (1D)

無可用資料

買價	1.39
市值	3.08M
營收 (ttm)	n/a
淨利（ttm）	-19.29M
	3.27
	355.6
	0
	n/a
P/B (ttm)	0.12
P/S (ttm)	n/a
財報日期	n/a

賣價	1.39
成交量	3,958,077
20 日平均成交量	5,409,009
開盤價	1.93
前收盤價	2.23
當日區間	1.31 - 1.94
52 週範圍	0.95 - 81.00
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 PPCB

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreemen...

[閱讀更多]

產業 Biotechnology

類股 Healthcare

IPO 日期 Jan 7, 2013

員工 1

證券交易所 NasdaqCM

股票代號 PPCB

網站 https://www.propanc.com

完整的公司簡介